143 related articles for article (PubMed ID: 21427174)
1. PML is a key component for the differentiation of myeloid progenitor cells to macrophages.
Khalfin-Rabinovich Y; Weinstein A; Levi BZ
Int Immunol; 2011 Apr; 23(4):287-96. PubMed ID: 21427174
[TBL] [Abstract][Full Text] [Related]
2. Interferon regulatory factor-8 is indispensable for the expression of promyelocytic leukemia and the formation of nuclear bodies in myeloid cells.
Dror N; Rave-Harel N; Burchert A; Azriel A; Tamura T; Tailor P; Neubauer A; Ozato K; Levi BZ
J Biol Chem; 2007 Feb; 282(8):5633-40. PubMed ID: 17189268
[TBL] [Abstract][Full Text] [Related]
3. PML positively regulates interferon gamma signaling.
El Bougrini J; Dianoux L; Chelbi-Alix MK
Biochimie; 2011 Mar; 93(3):389-98. PubMed ID: 21115099
[TBL] [Abstract][Full Text] [Related]
4. Interferon regulatory factor-8-driven myeloid differentiation is regulated by 12/15-lipoxygenase-mediated redox signaling.
Kinder M; Thompson JE; Wei C; Shelat SG; Blair IA; Carroll M; Puré E
Exp Hematol; 2010 Nov; 38(11):1036-1046.e1-4. PubMed ID: 20647030
[TBL] [Abstract][Full Text] [Related]
5. Promyelocytic Leukemia Protein Isoform II Promotes Transcription Factor Recruitment To Activate Interferon Beta and Interferon-Responsive Gene Expression.
Chen Y; Wright J; Meng X; Leppard KN
Mol Cell Biol; 2015 May; 35(10):1660-72. PubMed ID: 25733689
[TBL] [Abstract][Full Text] [Related]
6. ICSBP/IRF-8: its regulatory roles in the development of myeloid cells.
Tamura T; Ozato K
J Interferon Cytokine Res; 2002 Jan; 22(1):145-52. PubMed ID: 11846985
[TBL] [Abstract][Full Text] [Related]
7. PML-retinoic acid receptor alpha inhibits PML IV enhancement of PU.1-induced C/EBPepsilon expression in myeloid differentiation.
Yoshida H; Ichikawa H; Tagata Y; Katsumoto T; Ohnishi K; Akao Y; Naoe T; Pandolfi PP; Kitabayashi I
Mol Cell Biol; 2007 Aug; 27(16):5819-34. PubMed ID: 17562868
[TBL] [Abstract][Full Text] [Related]
8. Role and fate of PML nuclear bodies in response to interferon and viral infections.
Regad T; Chelbi-Alix MK
Oncogene; 2001 Oct; 20(49):7274-86. PubMed ID: 11704856
[TBL] [Abstract][Full Text] [Related]
9. Role of promyelocytic leukemia protein in host antiviral defense.
Geoffroy MC; Chelbi-Alix MK
J Interferon Cytokine Res; 2011 Jan; 31(1):145-58. PubMed ID: 21198351
[TBL] [Abstract][Full Text] [Related]
10. B Cell Linker Protein (BLNK) Is a Selective Target of Repression by PAX5-PML Protein in the Differentiation Block That Leads to the Development of Acute Lymphoblastic Leukemia.
Imoto N; Hayakawa F; Kurahashi S; Morishita T; Kojima Y; Yasuda T; Sugimoto K; Tsuzuki S; Naoe T; Kiyoi H
J Biol Chem; 2016 Feb; 291(9):4723-31. PubMed ID: 26703467
[TBL] [Abstract][Full Text] [Related]
11. Critical role of presenilin-dependent γ-secretase activity in DNA damage-induced promyelocytic leukemia protein expression and apoptosis.
Song H; Boo JH; Kim KH; Kim C; Kim YE; Ahn JH; Jeon GS; Ryu H; Kang DE; Mook-Jung I
Cell Death Differ; 2013 Apr; 20(4):639-48. PubMed ID: 23306558
[TBL] [Abstract][Full Text] [Related]
12. Differential expression and distinct functions of IFN regulatory factor 4 and IFN consensus sequence binding protein in macrophages.
Marecki S; Atchison ML; Fenton MJ
J Immunol; 1999 Sep; 163(5):2713-22. PubMed ID: 10453013
[TBL] [Abstract][Full Text] [Related]
13. Promyelocytic leukemia nuclear bodies are predetermined processing sites for damaged DNA.
Bøe SO; Haave M; Jul-Larsen A; Grudic A; Bjerkvig R; Lønning PE
J Cell Sci; 2006 Aug; 119(Pt 16):3284-95. PubMed ID: 16868026
[TBL] [Abstract][Full Text] [Related]
14. Direct transcriptional activation of promyelocytic leukemia protein by IFN regulatory factor 3 induces the p53-dependent growth inhibition of cancer cells.
Kim TK; Lee JS; Oh SY; Jin X; Choi YJ; Lee TH; Lee Eh; Choi YK; You S; Chung YG; Lee JB; DePinho RA; Chin L; Kim H
Cancer Res; 2007 Dec; 67(23):11133-40. PubMed ID: 18056437
[TBL] [Abstract][Full Text] [Related]
15. Dynamics of component exchange at PML nuclear bodies.
Weidtkamp-Peters S; Lenser T; Negorev D; Gerstner N; Hofmann TG; Schwanitz G; Hoischen C; Maul G; Dittrich P; Hemmerich P
J Cell Sci; 2008 Aug; 121(Pt 16):2731-43. PubMed ID: 18664490
[TBL] [Abstract][Full Text] [Related]
16. Promyelocytic leukemia-nuclear body formation is an early event leading to retinoic acid-induced differentiation of neuroblastoma cells.
Delaune A; Corbière C; Benjelloun FD; Legrand E; Vannier JP; Ripoll C; Vasse M
J Neurochem; 2008 Jan; 104(1):89-99. PubMed ID: 17986232
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of PML is essential for activation of C/EBP epsilon and PU.1 to accelerate granulocytic differentiation.
Tagata Y; Yoshida H; Nguyen LA; Kato H; Ichikawa H; Tashiro F; Kitabayashi I
Leukemia; 2008 Feb; 22(2):273-80. PubMed ID: 17989716
[TBL] [Abstract][Full Text] [Related]
18. Knocking down PML impairs p53 signaling transduction pathway and suppresses irradiation induced apoptosis in breast carcinoma cell MCF-7.
Bao-Lei T; Zhu-Zhong M; Yi S; Jun-Jie Q; Yan D; Hua L; Bin L; Guo-Wei Z; Zhi-Xian S
J Cell Biochem; 2006 Feb; 97(3):561-71. PubMed ID: 16215989
[TBL] [Abstract][Full Text] [Related]
19. AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation.
Li Q; He Y; Wei L; Wu X; Wu D; Lin S; Wang Z; Ye Z; Lin SC
Oncogene; 2011 Mar; 30(10):1194-204. PubMed ID: 21057547
[TBL] [Abstract][Full Text] [Related]
20. TRIM19/PML Restricts HIV Infection in a Cell Type-Dependent Manner.
Kahle T; Volkmann B; Eissmann K; Herrmann A; Schmitt S; Wittmann S; Merkel L; Reuter N; Stamminger T; Gramberg T
Viruses; 2015 Dec; 8(1):. PubMed ID: 26703718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
